Impact of the Female Genital Microbiota on Outcomes of Assisted Reproductive Techniques
- PMID: 40564051
- PMCID: PMC12189100
- DOI: 10.3390/biomedicines13061332
Impact of the Female Genital Microbiota on Outcomes of Assisted Reproductive Techniques
Abstract
The female genital microbiota plays a critical role in reproductive health and has recently emerged as a key factor influencing the outcomes of Assisted Reproductive Techniques (ARTs). Beyond traditional concerns about vaginal dysbiosis and infections such as bacterial vaginosis or mycoses, recent evidence highlights the broader impact of genital microbial communities, including the vaginal, cervical, and endometrial niches, on ART success rates. New findings suggest that specific bacterial profiles, as well as shifts in the virome and mycobiome, can significantly affect implantation and pregnancy outcomes. Non-invasive biomarkers such as menstrual blood have also been proposed for assessing endometrial receptivity. Furthermore, growing attention has been directed towards methodological challenges such as contamination risks during microbiota sampling which may influence study reliability. This review synthesizes the latest data on the relationship between the female genital microbiota and ART outcomes, with a focus on standardized microbiological analysis techniques and specific patient populations such as those experiencing recurrent implantation to optimize ART success based on microbiota profiling.
Keywords: ART; assisted reproductive techniques; bacteria; endometrial microbiota; fertility; genital microbiota; vaginal microbiota.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Antibiotics prior to or at the time of embryo transfer in ART.Cochrane Database Syst Rev. 2023 Nov 23;11(11):CD008995. doi: 10.1002/14651858.CD008995.pub3. Cochrane Database Syst Rev. 2023. PMID: 37994721 Free PMC article.
-
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. doi: 10.1002/14651858.CD002126.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. PMID: 16235297 Updated.
-
Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Cochrane Database Syst Rev. 2002;(3):CD001124. doi: 10.1002/14651858.CD001124. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2014 Jul 29;(7):CD001124. doi: 10.1002/14651858.CD001124.pub2. PMID: 12137619 Updated.
-
Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer).Cochrane Database Syst Rev. 2018 Feb 28;2(2):CD011809. doi: 10.1002/14651858.CD011809.pub2. Cochrane Database Syst Rev. 2018. PMID: 29489026 Free PMC article.
-
Pain management for women in labour: an overview of systematic reviews.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD009234. doi: 10.1002/14651858.CD009234.pub2. Cochrane Database Syst Rev. 2012. PMID: 22419342 Free PMC article.
References
-
- Mendling W. Microbiota of the Human Body: Implications in Health and Disease. Springer; Cham, Switzerland: 2016. Vaginal Microbiota; pp. 83–93. - DOI
Publication types
LinkOut - more resources
Full Text Sources